• In August 2026, Archer-Daniels-Midland announced plans to invest about US$100 million to expand capacity at four existing U.S. oilseed-crushing plants serving food, animal feed, and biofuels markets, while also disclosing that director Lei Z. Schlitz will step down from the Board effective December 31, 2026 following a voluntary change in her primary employment.
• By opting to boost output at current facilities for roughly a quarter of the cost of building a new plant, ADM is signaling a capital-efficient approach to meeting demand across its core agricultural and biofuel value chains.
• We’ll now examine how ADM’s capital-efficient oilseed crush expansion shapes its investment narrative around biofuel exposure and margin potential.

The future of work is here. Discover the 38 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

Archer-Daniels-Midland Investment Narrative Recap

To own Archer-Daniels-Midland, you need to believe in its role as a scaled, globally integrated processor that can earn acceptable returns across agricultural cycles, including biofuels. The US$100 million oilseed crush expansion modestly supports the near term catalyst around biofuel exposed margins, but does not fundamentally change the biggest current risk from policy and regulatory uncertainty that can still weigh on Ag Services & Oilseeds earnings.

The most relevant recent news alongside the plant expansion is ADM’s settlement with the SEC in January 2026, which closed a regulatory investigation with a US$40 million payment and no further DOJ action. Together, the plant upgrades and resolved inquiry frame a business leaning into core processing capacity while working through residual governance risks that had concerned some investors focused on compliance costs and confidence in reported results.

Yet, while this expansion can look constructive, investors still need to be aware of how biofuel policy volatility could...

Archer-Daniels-Midland's narrative projects $88.5 billion revenue and $2.3 billion earnings by 2029.

Uncover how Archer-Daniels-Midland's forecasts yield a $78.70 fair value, in line with its current price.

Exploring Other Perspectives

Some analysts see this news very differently, with the most pessimistic group previously assuming just 1.2 percent annual revenue growth and earnings of about US$2.4 billion by 2029, so you should weigh ADM’s new crush expansion against both the consensus view and concerns about higher structural manufacturing costs that could keep margins tighter than many expect.

Explore 4 other fair value estimates on Archer-Daniels-Midland - why the stock might be worth as much as 54% more than the current price!

Decide For Yourself

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Archer-Daniels-Midland research is our analysis highlighting 3 key rewards that could impact your investment decision.
• Our free Archer-Daniels-Midland research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Archer-Daniels-Midland's overall financial health at a glance.

Want Some Alternatives?

The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:

• Uncover the next big thing with 22 elite penny stocks that balance risk and reward.
• The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 18 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
• AI is about to change healthcare. These 42 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.